Bellerophon Therapeutics, Inc. Derivative Liability, Current
Bellerophon Therapeutics, Inc. had Derivative Liability, Current of $5.21 million as of 2016-12-31, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2017-11-07
- 2016-12-31: Derivative Liability, Current $5.21M.
| Period end | Derivative Liability, Current |
|---|---|
| 2016-12-31 | $5.21M 10-Q · filed 2017-11-07 |